West Pharmaceutical Services, Inc. Share Price Mexican S.E.

Equities

WST *

US9553061055

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 03:30:00 09/05/2024 am IST 5-day change 1st Jan Change
6,080 MXN -1.78% Intraday chart for West Pharmaceutical Services, Inc. -.--% -8.25%

Financials

Sales 2024 * 301.08Cr 5.53TCr 25TCr Sales 2025 * 327.96Cr 6.03TCr 27TCr Capitalization 2.29TCr 42TCr 1,91400Cr
Net income 2024 * 57Cr 1.05TCr 4.78TCr Net income 2025 * 67Cr 1.24TCr 5.61TCr EV / Sales 2024 * 7.41 x
Net cash position 2024 * 62Cr 1.13TCr 5.15TCr Net cash position 2025 * 101.51Cr 1.87TCr 8.48TCr EV / Sales 2025 * 6.68 x
P/E ratio 2024 *
40.8 x
P/E ratio 2025 *
35.5 x
Employees 10,600
Yield 2024 *
0.3%
Yield 2025 *
0.35%
Free-Float 96.38%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing MT
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023. CI
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
More news
1 day-1.78%
1 month-1.78%
3 months+0.60%
6 months-8.25%
Current year-8.25%
More quotes
1 month
6 066.53
Extreme 6066.53
6 080.00
Current year
6 043.95
Extreme 6043.95
6 190.16
1 year
6 043.95
Extreme 6043.95
6 682.31
3 years
5 595.91
Extreme 5595.91
9 649.00
5 years
5 595.91
Extreme 5595.91
9 649.00
10 years
5 595.91
Extreme 5595.91
9 649.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 24/15/24
Director of Finance/CFO 55 21/18/21
Chief Tech/Sci/R&D Officer 52 26/18/26
Members of the board TitleAgeSince
Director/Board Member 66 01/11/01
Chief Executive Officer 55 24/15/24
Director/Board Member 63 12/16/12
More insiders
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
314.7 USD
Average target price
397.1 USD
Spread / Average Target
+26.20%
Consensus